与正常肾脏相比，肾细胞癌中溶酶体半胱氨酸蛋白酶的浓度降低。
Concentrations of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidney.
作者信息
Kirschke H, Clausen T, Göhring B, Günther D, Heucke E, Laube F, Löwe E, Neef H, Papesch H, Peinze S, Plehn G, Rebmann U, Rinne A, Rüdrich R, Weber E
机构信息
Institute of Physiological Chemistry, Martin-Luther University, Halle (Saale), Germany.
出版信息
J Cancer Res Clin Oncol. 1997;123(7):402-6. doi: 10.1007/BF01240124.
Abstract
Renal cell carcinoma contains significantly lower concentrations of the lysosomal cysteine proteases, cathepsins B, C, H, L and S, than does normal kidney, as shown by several methods, such as activity determination, enzyme-linked immunosorbent assay, immunoblotting and immunohistochemistry. The same low levels of enzyme activity and concentration have been determined in renal cell carcinoma metastases in the lung. Our results on the decreased concentration of cysteine peptidases at the protein level would seem to conflict with earlier results on an increased concentration of the cathepsin L mRNA in renal cell carcinoma.
摘要
几种方法（如活性测定、酶联免疫吸附测定、免疫印迹和免疫组织化学）显示，肾细胞癌中溶酶体半胱氨酸蛋白酶组织蛋白酶B、C、H、L和S的浓度显著低于正常肾脏。在肺肾细胞癌转移灶中也测定到了同样低水平的酶活性和浓度。我们关于蛋白质水平半胱氨酸肽酶浓度降低的结果，似乎与早期关于肾细胞癌中组织蛋白酶L mRNA浓度升高的结果相矛盾。
相似文献
1
Concentrations of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidney.与正常肾脏相比，肾细胞癌中溶酶体半胱氨酸蛋白酶的浓度降低。
J Cancer Res Clin Oncol. 1997;123(7):402-6. doi: 10.1007/BF01240124.
2
Cathepsins B, H, L and cysteine proteinase inhibitors in renal cell carcinoma: no evidence for dysregulated proteolytic balance.肾细胞癌中的组织蛋白酶B、H、L和半胱氨酸蛋白酶抑制剂：蛋白水解平衡失调无证据
J Cancer Res Clin Oncol. 1998 Jan;124(1):60-1. doi: 10.1007/s004320050135.
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理（2025年结石病专家共识）
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
6
Calcium-dependent pathway as a primary cause of hypoxic RGC damage in monkey retinal explants.钙依赖途径是猴视网膜外植体中缺氧性视网膜神经节细胞损伤的主要原因。
PLoS One. 2025 Jul 11;20(7):e0327246. doi: 10.1371/journal.pone.0327246. eCollection 2025.
7
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.用于管理1型糖尿病患者血糖水平的混合闭环系统：系统评价与经济建模
Health Technol Assess. 2024 Dec;28(80):1-190. doi: 10.3310/JYPL3536.
8
WITHDRAWN: Antidepressants for depression in medical illness.撤回：用于治疗躯体疾病伴发抑郁症的抗抑郁药。
Cochrane Database Syst Rev. 2007 Jul 18;2000(4):CD001312. doi: 10.1002/14651858.CD001312.pub2.
9
Targeted therapy for advanced renal cell carcinoma.晚期肾细胞癌的靶向治疗
Cochrane Database Syst Rev. 2008 Apr 16;2008(2):CD006017. doi: 10.1002/14651858.CD006017.pub2.
10
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
引用本文的文献
1
Appraising the causal role of cathepsins in genitourinary carcinoma: a two-sample mendelian randomization and prospective study based on 36,225 individuals.评估组织蛋白酶在泌尿生殖系统癌中的因果作用：一项基于36225名个体的两样本孟德尔随机化和前瞻性研究。
Discov Oncol. 2025 Mar 31;16(1):435. doi: 10.1007/s12672-025-02219-6.
2
Proteome profiling of clear cell renal cell carcinoma in von Hippel-Lindau patients highlights upregulation of Xaa-Pro aminopeptidase-1, an anti-proliferative and anti-migratory exoprotease.对冯·希佩尔-林道病患者的透明细胞肾细胞癌进行蛋白质组分析，结果显示Xaa-Pro氨肽酶-1上调，这是一种具有抗增殖和抗迁移作用的外切蛋白酶。
Oncotarget. 2017 Oct 19;8(59):100066-100078. doi: 10.18632/oncotarget.21929. eCollection 2017 Nov 21.
3
Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma.术前血清胱抑素-C作为肾细胞癌预后的潜在生物标志物。
PLoS One. 2017 Jun 6;12(6):e0178823. doi: 10.1371/journal.pone.0178823. eCollection 2017.
本文引用的文献
1
Sequence analysis and distribution of two new human cathepsin L splice variants.
FEBS Lett. 1996 Oct 7;394(3):345-8. doi: 10.1016/0014-5793(96)00986-6.
2
Cloning, genomic organization, and chromosomal localization of human cathepsin L.人组织蛋白酶L的克隆、基因组组织及染色体定位
J Biol Chem. 1993 Jan 15;268(2):1039-45.
3
Proenzyme from of cathepsin L produced by thymic epithelial cells promotes proliferation of immature thymocytes in the presence of IL-1, IL-7, and anti-CD3 antibody.胸腺上皮细胞产生的组织蛋白酶L的酶原形式在白细胞介素-1、白细胞介素-7和抗CD3抗体存在的情况下促进未成熟胸腺细胞的增殖。
Cell Immunol. 1993 Aug;150(1):124-36. doi: 10.1006/cimm.1993.1184.
4
Purification, characterization, and cDNA cloning of procathepsin L from the culture medium of NIH-Sape-4, an embryonic cell line of Sarcophaga peregrina (flesh fly), and its involvement in the differentiation of imaginal discs.从棕尾别麻蝇（肉蝇）胚胎细胞系NIH-Sape-4的培养基中纯化、鉴定组织蛋白酶L原并进行cDNA克隆，以及其在成虫盘分化中的作用。
J Biol Chem. 1994 May 27;269(21):15258-64.
5
Cathepsin B in tumors, normal tissue and isolated cells from the human lung.人肺肿瘤、正常组织及分离细胞中的组织蛋白酶B
Anticancer Res. 1994 May-Jun;14(3A):1169-76.
6
7
Hybridoma cells producing antibodies to cathepsin L have greatly reduced potential for tumour growth.产生组织蛋白酶L抗体的杂交瘤细胞具有大大降低的肿瘤生长潜力。
J Cancer Res Clin Oncol. 1994;120(9):564-7. doi: 10.1007/BF01221037.
8
Urinary excretion of cathepsin B and cystatins as parameters of tubular damage.尿组织蛋白酶B和胱抑素的排泄作为肾小管损伤的参数。
Kidney Int Suppl. 1994 Nov;47:S64-7.
9
10
Cathepsin B, Cathepsin H, and cathepsin L.组织蛋白酶B、组织蛋白酶H和组织蛋白酶L。
Methods Enzymol. 1981;80 Pt C:535-61. doi: 10.1016/s0076-6879(81)80043-2.
Zotero 插件